NEW BRUNSWICK, N.J.,
Jan. 6, 2020 /PRNewswire/ --
Nominations are now being accepted for the 2020 Dr. Paul Janssen Award for Biomedical Research. This
prestigious award celebrates dedicated researchers and champions of
science whose basic or clinical discoveries have made, or have the
potential to make, significant contributions toward improving human
health. Nominations will be accepted until February 29, 2020, at www.pauljanssenaward.com
for consideration by an independent selection committee of
world-renowned scientists. The winning scientist(s) will be
announced in spring 2020 and receive a $200,000 cash prize.
The Dr. Paul Janssen Award for
Biomedical Research honors Dr. Paul
Janssen (1926-2003), one of the most productive
pharmaceutical scientists of the 20th century. He was responsible
for breakthrough treatments in disease areas, including pain
management, psychiatry, infectious disease and gastroenterology.
Janssen founded Janssen Pharmaceutica, N.V., now part of the
Johnson & Johnson (NYSE: JNJ) Family of Companies.
"Researchers pushing the boundaries of science are innovators
and heroes. Their breakthroughs have the power to improve the lives
of people around the world," said Paul
Stoffels, M.D., Vice Chairman of the Executive Committee and
Chief Scientific Officer, Johnson & Johnson. "It is a privilege
to recognize those whose vision and commitment make scientific
progression possible. We are proud to honor Dr. Paul's legacy by
recognizing outstanding researchers who are making a lasting impact
on our world as he did."
In 2019, the Dr. Paul Janssen
Award recognized Drs. Franz-Ulrich Hartl
M.D., Director, Max Planck Institute of Biochemistry and
Arthur Horwich, M.D., Sterling
Professor of Genetics and Professor of Pediatrics, Yale School of Medicine and Investigator, Howard
Hughes Medical Institute, for their revolutionary insights into
chaperone-mediated protein folding. They joined 16 other scientists
who have received the Dr. Paul
Janssen Award since its founding in 2004, including three
who have gone on to win the Nobel Prize.
"Solving the world's most pressing health problems requires
continuous advancement of the science underlying biological
processes," said Richard P. Lifton, M.D., Ph.D., president of
Rockefeller University. "This year, I'm
honored to be chairing the selection committee, which reviews
nominations from academia, industry, government and scientific
institutions around the world. Each is a champion of science whose
work exemplifies the leadership and passion that shaped Dr. Paul's
career."
Previous Award winners include:
- 2019 – Drs. Franz-Ulrich Hartl
M.D., and Arthur Horwich,
M.D.
- 2018 – James Allison, Ph.D.,
Nobel Laureate
- 2017 – Douglas Wallace,
Ph.D.
- 2016 – Yoshinori Ohsumi, Ph.D.,
Nobel Laureate
- 2015 – Bert Vogelstein,
M.D.
- 2014 – Emmanuelle Charpentier,
Ph.D. and Jennifer Doudna,
Ph.D.
- 2013 – David Julius, Ph.D.
- 2012 – Victor Ambros, Ph.D., and
Gary Ruvkun, Ph.D.
- 2011 – Napoleone Ferrara,
M.D.
- 2010 – Anthony S. Fauci, M.D.
and Erik De Clercq, M.D.,
Ph.D.,
- 2009 – Axel Ullrich, Ph.D.
- 2008 – Professor Marc Feldmann,
FMedSci, FAA, FRS, Emeritus Professor
and Sir Ravinder Maini, FRCP,
FMedSci, FRS
- 2006 – Craig Mello, Ph.D., Nobel
Laureate
About The Dr. Paul Janssen
Award for Biomedical Research
Established by Johnson &
Johnson, The Dr. Paul Janssen Award
salutes champions of science and the most passionate and creative
scientists in basic or clinical research whose scientific
achievements have made, or have strong potential to make, a
measurable impact on human health.
The Award is named after the scientist who founded Janssen
Pharmaceutica, N.V. in 1953. Known to his colleagues as "Dr. Paul,"
Janssen helped save millions of lives through his contribution to
the discovery and development of more than 80 medicines, four of
which remain on the World Health Organization's list of essential
medicines.
In 1961, Janssen Pharmaceutica, N.V. joined the Johnson &
Johnson Family of Companies. Janssen's legacy continues to inspire
Johnson & Johnson and its commitment to finding innovative
cures for unmet medical needs. Visit www.pauljanssenaward.com for
more information.
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation
of vibrant lives, thriving communities and forward progress. That's
why for more than 130 years, we have aimed to keep people well at
every age and every stage of life. Today, as the world's largest
and most broadly-based health care company, we are committed to
using our reach and size for good. We strive to improve access and
affordability, create healthier communities, and put a healthy
mind, body and environment within reach of everyone, everywhere. We
are blending our heart, science and ingenuity to profoundly change
the trajectory of health for humanity. To learn more, visit
www.jnj.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dr-paul-janssen-award-for-biomedical-research-issues-2020-call-for-nominations-to-celebrate-champions-of-science-300981439.html
SOURCE Johnson & Johnson